On 31 January 2022, the US FDAannouncedthat they approved the second COVID-19 vaccine – the Moderna COVID-19 Vaccine. It is now allowed to be marketed as theModerna Spikevaxvaccine for the prevention of COVID-19 disease in individuals18 years of age and older. The Moderna vaccine continu...
Nora Disis is Director of the Cancer Vaccine Institute at the University of Washington School of Medicine, and the founding editor ofJAMA Oncology. DISIS: One of the reasons why mRNA was able to advance so rapidly is that its safety profile in many, many, many cancer patients had already be...
Some people claim that COVID-19 vaccines can cause a form of AIDS-like immunodeficiency called vaccine-acquired immune deficiency syndrome (VAIDS). VAIDS is not a real medical condition, despite the #VAIDS hashtag being used on Twitter since at least December 2021. The Centers for Disease Co...
Intellectual-property rightsVaccinesSARS-CoV-2Collaborators are locked in a high-stakes dispute over which researchers should be named as inventors on a key vaccine patent application.doi:10.1038/d41586-021-03535-xHeidi LedfordNatureNature
Moderna announces upcoming trial of a vaccine candidate against flu; April 11-17 marks Black Maternal Health Week; the European Commission will not renew COVID-19 vaccine contracts with Johnson & Johnson and AstraZeneca when they expire next year....
getty images both pfizer and moderna have mrna-based vaccines nearing the very end of clinical development and testing. there's no reason to think mrna is the only kind of vaccine option—it's just the fastest in this particular situation, with a dozen other options in advanced developm...
Modernahas filed for FDA approval of its own updated mRNA shot targeting JN.1, according to arelease. The company said manufacturing is underway and doses of the new vaccine will be ready to ship in the U.S. as early as August.
johnson's janssen contains a human adenovirus called ad26, which has been modified so it cannot replicate and instead carries coronavirus genes. the company used the same method to create its approved ebola vaccine as well as vaccines for other diseases that are still in clinical trials. related...
“If you take the allegory of the immune system as an army, the number of soldiers is higher, but the soldiers themselves are not different,” Schober said. In total, the man got eight vaccine formulations, including mRNA vaccines from Pfizer/BioNTech and Moderna, a vector-based vaccine from...
“We cannot not move now . . . because it would take months to get the next one ready in case we need it,” Stéphane Bancel, Moderna’s chief executive, told the Financial Times. Moderna’s vaccine, which like the BioNTech/Pfizer shot relies on mRNA technology, will be easier...